GVCAX | VMVAX | GVCAX / VMVAX | |
Total Expense Ratio | 1.45 | 0.07 | 2,071% |
Annual Report Gross Expense Ratio | 1.45 | 0.07 | 2,071% |
Fund Existence | 15 years | 14 years | - |
Gain YTD | 16.126 | 5.735 | 281% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 3000 | 33% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 224M | 31B | 1% |
Annual Yield % from dividends | 0.49 | 2.22 | 22% |
Returns for 1 year | 10.70 | 7.05 | 152% |
Returns for 3 years | -4.65 | 20.06 | -23% |
Returns for 5 years | -6.06 | 68.81 | -9% |
Returns for 10 years | -28.85 | 99.07 | -29% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
WIW | 8.84 | 0.08 | +0.91% |
Western Asset Inflation-Linked Opportunities & Income Fund | |||
VCLT | 75.75 | 0.21 | +0.28% |
Vanguard Long-Term Corporate Bd ETF | |||
SAWS | 20.69 | N/A | N/A |
AAM Sawgrass US Small Cap Quality Growth ETF | |||
IGA | 9.82 | -0.01 | -0.10% |
Voya Global Advantage AND Premium Opportunity Fund | |||
LRNZ | 41.54 | -1.18 | -2.77% |
TrueShares Tech, AI and Deep Lrng ETF |